Product complaint # : (b)(4).Date sent to the fda: 01/27/2020.Three pictures were received for analysis.Upon visual inspection of two photos, damage and wrinkles at open foil could be observed; also, a picture of the one open box of product could be observed.However, no conclusion could be reached.Also, one open sample of product was received for analysis.During visual inspection of the sample, the box was received crushed; also, the foil packet was examined and damaged on the top was observed.The damage was examined under magnification and the integrity of the package was not compromised since damage did not cause perforation in the foil.Additionally, wrinkles were noted due to manipulation of the package.The manufacturing records were reviewed and the manufacturing/packaging criteria were met prior to the release of this batch.Per the sample condition, it could not be determined what may have caused the reported incident.
|